P3 Health Partners Inc.
PIII
$8.86
$0.192.19%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 370.69M | 362.12M | 379.16M | 388.49M | 346.86M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 370.69M | 362.12M | 379.16M | 388.49M | 346.86M |
Cost of Revenue | 410.22M | 401.92M | 365.17M | 382.06M | 367.68M |
Gross Profit | -39.54M | -39.80M | 13.99M | 6.43M | -20.82M |
SG&A Expenses | 31.83M | 33.55M | 27.02M | 27.72M | 25.15M |
Depreciation & Amortization | 21.15M | 21.67M | 21.69M | 21.54M | 21.63M |
Other Operating Expenses | 37.93M | 18.17M | -3.40M | 1.00M | -3.34M |
Total Operating Expenses | 501.13M | 475.31M | 410.49M | 432.32M | 411.12M |
Operating Income | -130.45M | -113.19M | -31.33M | -43.83M | -64.26M |
Income Before Tax | -124.20M | -106.46M | -27.81M | -47.53M | -67.34M |
Income Tax Expenses | 4.95M | -3.61M | 968.00K | 2.07M | 1.77M |
Earnings from Continuing Operations | -129.15M | -102.85M | -28.77M | -49.61M | -69.11M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 70.53M | 56.34M | 16.75M | 30.91M | 43.65M |
Net Income | -58.62M | -46.51M | -12.02M | -18.70M | -25.46M |
EBIT | -130.45M | -113.19M | -31.33M | -43.83M | -64.26M |
EBITDA | -109.29M | -91.52M | -9.64M | -22.29M | -42.63M |
EPS Basic | -25.14 | -14.37 | -4.40 | -7.86 | -11.04 |
Normalized Basic EPS | -4.44 | -4.35 | -0.23 | 0.50 | 0.68 |
EPS Diluted | -29.04 | -15.70 | -7.37 | -8.00 | -29.97 |
Normalized Diluted EPS | -4.44 | -4.27 | -0.22 | 0.50 | 0.68 |
Average Basic Shares Outstanding | 2.33M | 3.24M | 2.73M | 2.38M | 2.31M |
Average Diluted Shares Outstanding | 2.33M | 3.29M | 2.82M | 2.38M | 2.31M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |